Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 1;61(31):e202207153.
doi: 10.1002/anie.202207153. Epub 2022 Jun 23.

Umpolung AlaB Reagents for the Synthesis of Non-Proteogenic Amino Acids, Peptides and Proteins

Affiliations

Umpolung AlaB Reagents for the Synthesis of Non-Proteogenic Amino Acids, Peptides and Proteins

Feng Zhu et al. Angew Chem Int Ed Engl. .

Abstract

Non-proteogenic amino acids and functionalized peptides are important motifs in modern drug discovery. Here we report that AlaB can serve as universal building blocks in the synthesis of a diverse collection of modified amino acids, peptides, and proteins. First, we develop the synthesis of AlaB from redox-active esters of aspartic acid resulting in a series of β-boronoalanine derivatives. Next, we show that AlaB can be integrated into automated oligopeptide solid-phase synthesis. AlaB is compatible with common transformations used in preparative peptide chemistry such as native chemical ligation and radical desulfurization as showcased by total synthesis of AlaB -containing ubiquitin. Furthermore, AlaB reagents participate in Pd-catalyzed reactions, including C-C cross-couplings and macrocyclizations. Taken together, AlaB synthons are practical reagents to access modified peptides, proteins, and in the synthesis of cyclic/stapled peptides.

Keywords: AlaB; Boronoalanine; Macrocyclization; Non-Proteogenic Amino Acids; Peptides.

PubMed Disclaimer

Figures

Scheme 1.
Scheme 1.
AlaM as synthetic reagents for peptide and protein modifications.
Scheme 2.
Scheme 2.
Synthesis of AlaBPai and AlaBMIDA reagents. [a] Refers to conditions A. [b] Refers to conditions B.
Scheme 3.
Scheme 3.
Elaboration of AlaB into peptides and proteins.a [a] LC conditions: Agilent EC-C18 Poroshell, 40 °C, 1 mL/min; 5–65% MeCN/H2O with 0.05 % TFA over 1 h. Abbreviations: DIPEA=diisopropylethylamine; Gnd=guanidine; GSH=glutathione reduced; HBTU=(2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate; MPAA=mercaptophenylacetic acid; SPPS=solid-phase peptide synthesis; TCEP=(tris(2-carboxyethyl)phosphine; TFA=trifluoroacetic acid; TIPSH=triisopropylsilane; VA-044=2,2’-azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride.
Scheme 4.
Scheme 4.
Scope of Suzuki cross-coupling with AlaB. [a] Refers to 34A series. [b] Refers to 34B series. [c] K2CO3 at 60 °C; [d] PdCl2dppf (30 mol%), 72 h.
Scheme 5.
Scheme 5.
Macrocyclization of AlaB oligopeptides. aPdCl2dppf (10 mol%), Ag2O (2 equiv.) K2CO3 (3 equiv.) THF (50 mM). bMacrocycle derived from 35 (Boc-AlaBPai-AA2-AA3-Phe(m-Br)-OMe). cMacrocycle derived from 36 (Boc-Phe(m-Br)-AA2-AA3-AlaBPai-OMe).

References

    1. Fosgerau K, Hoffmann T, Drug Discov. Today 2015, 20, 122–128; - PubMed
    2. Lau JL, Dunn MK, Bioorg. Med. Chem 2018, 26, 2700–2707. - PubMed
    1. Sánchez-Navarro M, Teixidó M, Giralt E, Acc. Chem. Res 2017, 50, 1847–1854. - PubMed
    1. Walsh CT, O’Brien RV, Khosla C, Angew. Chem. Int. Ed 2013, 52, 7098–7124; - PMC - PubMed
    2. Xue YP, Cao CH, Zheng YG, Chem. Soc. Rev 2018, 47, 1516–1561; - PubMed
    3. Almhjell PJ, Boville CE, Arnold FH, Chem. Soc. Rev 2018, 47, 8980–8997; - PMC - PubMed
    4. Ding Y, Ting JP, Liu J, Al-Azzam S, Pandya P, Afshar S, Amino Acids 2020, 52, 1207–1226; - PMC - PubMed
    5. Hedges JB, Ryan KS, Chem. Rev 2020, 120, 3161–3209. - PubMed
    1. Wang J, Liu X, Feng X, Chem. Rev 2011, 111, 6947–6983. - PubMed
    1. Knowles WS, Acc. Chem. Res 1983, 16, 106–112;
    2. Nájera C, Sansano JM, Chem. Rev 2007, 107, 4584–4671. - PubMed

Publication types

LinkOut - more resources